Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Intervention1: Indicated homeopathic medicine in centesimal potency: Intervention is planned as administering indicated homeopathic medicines in centesimal potencies, as decided appropriate to the cas
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Duration of therapy: 3 months.
Con
Sponsors
D N De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of 18-65 yrs of age 2. Both sexes 3. Suffering from atopic dermatitis as per UK diagnostic criteria for atopic dermatitis and POSCORAD more than 10 4. Patients already undergoing treatment for atopic dermatitis may be recruited on completely stopping medicine and after wash-out phase of 1 month 5. Literate patients 6. Signed written informed consent to participate
Exclusion criteria
Exclusion criteria: 1. Patients too sick for consultation 2. Diagnosed case of unstable or psychiatric illness affecting quality of life (QoL) 3. Uncontrolled or life-threatening illness affecting QoL or any organ failure 4. Substance abuse and/or dependence 5. Pregnant and lactating women 6. Undergoing homoeopathic treatment for any chronic disease within last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient Oriented Score of Atopic Dermatitis (PO-SCORAD)Timepoint: At baseline, and every month up to 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Atopic Dermatitis Burden Scale for Adults (ADBSA)Timepoint: At baseline, and every month up to 3 months;Dermatology Life Quality Index (DLQI)Timepoint: At baseline, and every month up to 3 months | — |
Countries
India
Contacts
Public ContactSamit Dey
D.N.De Homoeopathic Medical College and Hospital
Outcome results
None listed